Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome-Reference-Cited by-同舟云学术

Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome

Published:2009-05-07 Issue:1 Volume:59 Page:27-34
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Venanzi Franco Maria,Petrini Massimiliano,Fiammenghi Laura,Bolli Elisabetta,Granato Anna Maria,Ridolfi Laura,Gabrielli Federica,Barucca Alessandra,Concetti Antonio,Ridolfi Ruggero,Riccobon Angela

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-009-0717-4.pdf

Reference38 articles.

1. Gilboa E (2007) DC-based cancer vaccines. J Clin Invest 117:1195–1203

2. Nestle FO, Alijagic S, Gilliet M et al (1998) Vaccination of melanoma patients with peptide- or tumour lysate-pulsed dendritic cells. Nat Med 4:328–332

3. Thurner B, Haendle I, Roder C et al (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190:1669–1678

4. Jonuleit H, Giesecke-Tuettenberg A, Tuting T et al (2001) A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 93:243–251

5. McLean K, Buckanovich RJ (2008) Myeloid cells functioning in tumour vascularization as a novel therapeutic target. Transl Res 151:59–67

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study;Journal of Translational Medicine;2014-07-22

2. A unique cytogenetic abnormality, t(2;7)(p13.1;p21.3), in a Philadelphia-positive chronic myeloid leukemia;Oncology Letters;2012-05-17

3. Dendritic cell-based vaccine in advanced melanoma;Melanoma Research;2011-12

4. Vaccines targeting the neovasculature of tumors;Vascular Cell;2011

5. Dendritic cells in cancer immunotherapy;European Journal of Immunology;2010-07-29